Deutetrabenazine for tardive dyskinesia: A systematic review of the efficacy and safety profile for this newly approved novel medication-What is the number needed to treat, number needed to harm and likelihood to be helped or harmed?

Deutetrabenazine for tardive dyskinesia: A systematic review of the efficacy and safety profile for this newly approved novel medication-What is the number needed to treat, number needed to harm and likelihood to be helped or harmed?

[Anonymous].  2017.  Deutetrabenazine for tardive dyskinesia: A systematic review of the efficacy and safety profile for this newly approved novel medication-What is the number needed to treat, number needed to harm and likelihood to be helped or harmed? International journal of clinical practice. 71(11)

Diabetes-induced hyperglycemia impairs male reproductive function: a systematic review.

What Can Big Data on Academic Interest Reveal about a Drug? Reflections in Three Major US Databases.

Lessons learned from bone marrow failure in systemic lupus erythematosus: Case reports and review of the literature.

The pathological and molecular diagnosis of malignant pleural mesothelioma: a literature review.

Gastrointestinal symptoms in children: Primary care and specialist interface.

Compliance and Regulatory Programs

Magnetic Resonance Imaging of Adipose Tissue in Metabolic Dysfunction.

Outcome reporting discrepancies between trial entries and published final reports of orthodontic randomized controlled trials.

A Comprehensive Review of Dorsomedial Prefrontal Cortex rTMS Utilizing a Double Cone Coil.